“…8 Besides, available experimental evidence did not reveal any harm. 9 However, even if more than 60% of patients responded to intratracheal milrinone and did not need additional inotropes, a second pump run, or even mechanical support, those who did not had an unfavorable clinical course and a substantially higher mortality. It is of note that upon logistic regression, this subset of patients may be identified by having severely reduced left ventricular function, undergoing prolonged CPB duration, and experiencing a more positive fluid balance, 6 factors that easily may be determined before trying to go off pump.…”